Publication Name	World Journal of Hepatology
Manuscript ID	72347
Country	United States

Received	2021-10-12 14:45
Peer-Review Started	2021-10-12 14:47
To Make the First Decision
Return for Revision	2021-12-02 07:49
Revised	2021-12-15 20:43
Second Decision	2022-02-11 05:50
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2022-02-13 16:52
Articles in Press	2022-02-13 16:52
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2022-03-08 01:23
Publish the Manuscript Online	2022-03-24 14:13

ISSN	1948-5182 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	Hepatitis E in immunocompromised individuals
Manuscript Source	Unsolicited Manuscript
All Author List	Konstantinos Damiris, Mohamad Aghaie Meybodi, Mumtaz Niazi and Nikolaos Pyrsopoulos
Funding Agency and Grant Number
Corresponding Author	Konstantinos Damiris, DO, MS, Doctor, Department of Medicine, Rutgers - New Jersey Medical School, 150 Bergen Street, Newark, New Jersey 07103, United States. kd705@njms.rutgers.edu
Key Words	Hepatitis E; Hepatitis E virus; Chronic hepatitis; Acute hepatitis; Immunocompromised; Liver transplant
Core Tip	Hepatitis E Virus is a leading cause of acute icteric hepatitis in developing countries. Despite being self- limiting in most cases, immunocompromised individuals are at a risk of chronic hepatitis, which can be life threatening. Hallmark of treatment includes reduction of immunosuppressive therapies followed by possible need of anti-viral therapy, which has shown to be ineffective.
Publish Date	2022-03-24 14:13
Citation	Damiris K, Aghaie Meybodi M, Niazi M, Pyrsopoulos N. Hepatitis E in immunocompromised individuals. World J Hepatol 2022; 14(3): 482-494
URL	https://www.wjgnet.com/1948-5182/full/v14/i3/482.htm
DOI	https://dx.doi.org/10.4254/wjh.v14.i3.482

Full Article (PDF)	WJH-14-482.pdf
Full Article (Word)	WJH-14-482.docx
Manuscript File	72347_Auto_Edited.docx
Answering Reviewers	72347-Answering reviewers.pdf
Audio Core Tip	72347-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	72347-Conflict-of-interest statement.pdf
Copyright License Agreement	72347-Copyright license agreement.pdf
Peer-review Report	72347-Peer-review(s).pdf
Scientific Misconduct Check	72347-Bing-Wang LL-2.png
Scientific Editor Work List	72347-Scientific editor work list.pdf